NFE2L2, nuclear factor, erythroid 2 like 2, 4780

N. diseases: 823; N. variants: 34
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model. 31670201 2020
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE Interestingly, sulforaphane-enriched broccoli sprouts improved the scopolamine-induced memory impairment in mice through Nrf2 activation, inhibiting neuronal apoptosis particularly through inhibition of caspase-3 activation which could lead to the neuroprotection against neurodegenerative disorders. 31049133 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE Natural Dietary Supplementation of Curcumin Protects Mice Brains against Ethanol-Induced Oxidative Stress-Mediated Neurodegeneration and Memory Impairment via Nrf2/TLR4/RAGE Signaling. 31096703 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE Overall, glyceollins showed neuroprotection against glutamate-induced damage, and attenuated scopolamine-induced memory deficits in an Nrf2-dependent manner. 29337893 2018
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE Our results indicate that FIR protects against MA-induced memory impairment via activations of the Nrf2-dependent glutathione synthetic system, and ERK 1/2 signaling by inhibition of the PKCδ gene. 29476655 2018
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE This research was conducted to evaluate the efficacy of SAC on alleviation of learning and memory deficits in streptozotocin (STZ)-diabetic rats and to explore involvement of toll-like receptor 4 (TLR4), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), nuclear factor-kappa B (NF-κB), and heme oxygenase 1 (HO-1) signaling cascade. 27887948 2017
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 AlteredExpression phenotype BEFREE Ellagic acid pretreatment of intrahippocampal amyloid beta-microinjected rats could dose-dependently improve learning and memory deficits via neuronal protection and at molecular level through mitigation of oxidative stress and acetylcholinesterase (AChE) activity and modulation of NF-κB/Nrf2/TLR4 signaling pathway. 28303372 2017
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 AlteredExpression phenotype BEFREE STZ (ICV) administration caused memory impairment along with the reduction of CBF, ATP level, and Nrf-2 expression. 27693383 2017
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.090 Biomarker phenotype BEFREE Further, memory deficit induced by scopolamine was restored by compound K, which did not inhibit acetylcholine esterase, in C57BL/6 mice but not in Nrf2 knockout mice as assessed by passive avoidance test, Y-maze and water maze tests, suggesting that scopolamine-induced memory impairment was overcome by the induction of Nrf2-mediated antioxidant enzymes by the compound K. Overall, our data indicate that compound K could be useful in prevention and treatment of reactive oxygen species-induced neurological disorders such as Alzheimer's disease. 27012214 2016